113104-25-9 - Names and Identifiers
113104-25-9 - Physico-chemical Properties
Molecular Formula | C11H6N4O4S
|
Molar Mass | 290.25 |
Storage Condition | 2-8°C(protect from light) |
In vitro study | NSC 228155 (100 μM) enhances EGFR tyrosine phosphorylation via action of SOD1. NSC 228155 (Compound 1) inhibits CREB- and VP16-CREB-mediated gene transcription in living HEK 293T cells with IC 50 s of 2.09 and 6.14 μM, respectively. NSC 228155 is not selective against CREB-mediated gene transcription in living HEK 293T cells. |
113104-25-9 - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 3.445 ml | 17.227 ml | 34.453 ml |
5 mM | 0.689 ml | 3.445 ml | 6.891 ml |
10 mM | 0.345 ml | 1.723 ml | 3.445 ml |
5 mM | 0.069 ml | 0.345 ml | 0.689 ml |
Last Update:2024-01-02 23:10:35
113104-25-9 - Reference Information
biological activity | NSC 228155 is an EGFR activator that binds to the extracellular domain of EGFR and induces phosphorylation of EGFR. NSC 228155 is a potent KIX-KID interaction inhibitor capable of inhibiting the interaction of the kinase-inducing domain (kid) of CREB and KIX (kidinteraction domain, derived from CBP), the IC50 value was 0.36 μm. |
Last Update:2024-04-09 21:04:16